Cytosorbents Corporation (CTSO)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-06) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-13) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | 8-K (2026-03-25) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-13) · 99.1 | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | 8-K (2025-05-14) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-31) · 99.1 | 8-K (2025-03-21) · 99.1 | 8-K (2025-03-04) · 99.1 | 8-K (2025-01-13) · 99.1 | 8-K (2025-01-03) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | 8-K (2024-10-01) · 99.1 | 8-K (2024-08-14) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-15) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-09) · 99.1 | 8-K (2023-08-02) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Changes In Stockholders' Equity (deficit) | — |
|
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Cash Flows | ||
| Condensed Consolidated Statements of Cash Flows (unaudited) (P) | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | — |
|
| Balance Sheet Components | ||
| Basis of Presentation | ||
| Basis of Presentation and Summary of Significant Accounting Policies | — |
|
| Commitments and Contingencies | ||
| Common Stock, Stock-based Compensation and Warrants | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Long-term Debt | ||
| Long-term Debt, Net | — |
|
| Nature of Business and Basis of Presentation | — |
|
| Net Income (loss) Per Share | — |
|
| Net Loss Per Share | ||
| Other Assets | — |
|
| Pay Vs Performance Disclosure | ||
| Principal Business Activity | — |
|
| Principal Business Activity and Summary of Significant Accounting Policies | ||
| Property and Equipment, Net | — |
|
| Quarterly Financial Results (unaudited) | — |
|
| Restatement of Previously Issued Financial Information | — |
|
| Restructuring | ||
| Retirement Plan | — |
|
| Revenue | ||
| Revenue and Segment Information | — |
|
| Segment Information | ||
| Significant Accounting Policies | — |
|
| Stock-based Compensation | — |
|
| Stockholders' Equity | ||
| Subsequent Events | ||